{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:29:50Z","timestamp":1791660590864,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-026-01739-w","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:45:49Z","timestamp":1775540749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deprescribing for Comorbidities in Patients with Cancer - a Systematic Review"],"prefix":"10.1007","volume":"28","author":[{"given":"In\u00eas","family":"Agonia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"1","key":"1739_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.","journal-title":"BMC Geriatr"},{"key":"1739_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0269216315573687","volume":"297","author":"D Domingues","year":"2015","unstructured":"Domingues D, Carneiro R, Costa I, Monteiro C, Shvetz Y, Barbosa AC, et al. Therapeutic futility in cancer patients at the time of palliative care transition: an analysis with a modified version of the medication appropriateness index. Palliat Med. 2015;297:643\u201351.","journal-title":"Palliat Med"},{"key":"1739_CR3","doi-asserted-by":"crossref","unstructured":"Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827.","DOI":"10.1001\/jamainternmed.2015.0324"},{"key":"1739_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.clon.2020.05.015","volume":"329","author":"JP Turner","year":"2020","unstructured":"Turner JP, Kantilal K, Kantilal K, Holmes HM, Koczwara B. Optimising medications for patients with cancer and multimorbidity: the case for deprescribing. Clin Oncol R Coll Radiol G B. 2020;329:609\u201317.","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"1739_CR5","unstructured":"World Health Organization. Medication Safety in Polypharmacy. 2019 p. 63. Report No.: WHO\/UHC\/SDS\/2019.11."},{"key":"1739_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/jpm.2023.0520","volume":"276","author":"S Masumoto","year":"2024","unstructured":"Masumoto S, Hosoi T, Nakamura T, Hamano J. Polypharmacy and potentially inappropriate medications in patients with advanced cancer: prevalence and associated factors at the end of life. J Palliat Med. 2024;276:749\u201355.","journal-title":"J Palliat Med"},{"key":"1739_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jgo.2021.02.027","volume":"126","author":"C Sirois","year":"2021","unstructured":"Sirois C, Turner JP, H\u00e9bert J. Health professionals\u2019 perspectives regarding polypharmacy in older patients with cancer: a mixed-design exploratory study. J Geriatr Oncol. 2021;126:881\u20137.","journal-title":"J Geriatr Oncol"},{"issue":"13","key":"1739_CR8","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/cncr.32044","volume":"125","author":"L Morin","year":"2019","unstructured":"Morin L, Todd A, Barclay S, Wastesson JW, Fastbom J, Johnell K. Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing? Cancer. 2019;125(13):2309\u201317.","journal-title":"Cancer"},{"key":"1739_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2024-004849","author":"J Fernandez-Fradejas","year":"2024","unstructured":"Fernandez-Fradejas J, Martinez-Barros H, Rexach-Cano L, Alvarez-Diaz AM, Delgado-Silveira E. Deprescribing in older patients with advanced cancer referred to palliative care. BMJ Support Palliat Care. 2024;14:e101565123. https:\/\/doi.org\/10.1136\/spcare-2024-004849.","journal-title":"BMJ Support Palliat Care"},{"issue":"2","key":"1739_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2710.2007.00793.x","volume":"32","author":"P Gallagher","year":"2007","unstructured":"Gallagher P, Barry P, O\u2019Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113\u201321.","journal-title":"J Clin Pharm Ther"},{"key":"1739_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/DHPS.S255893","volume":"13","author":"A Whitman","year":"2021","unstructured":"Whitman A, Erdeljac P, Jones C, Pillarella N, Nightingale G. Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings. Drug Healthc Patient Saf. 2021;13:101\u201316.","journal-title":"Drug Healthc Patient Saf"},{"key":"1739_CR12","first-page":"3025","volume":"296","author":"Y Suh","year":"2021","unstructured":"Suh Y, Ah YM, Lee E, Lee JY. Association of inappropriate polypharmacy with emergency department visits in older patients receiving anti-neoplastic therapy: a population-based study. Support Care Cancer. 2021;296:3025\u201334.","journal-title":"Support Care Cancer"},{"key":"1739_CR13","unstructured":"Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. Wiley; 2025. p. 1028."},{"issue":"1","key":"1739_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0529-x","volume":"17","author":"SM Thekdi","year":"2015","unstructured":"Thekdi SM, Trinidad A, Roth A. Psychopharmacology in cancer. Curr Psychiatry Rep. 2015;17(1):529.","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"1739_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/09540261.2013.842542","volume":"26","author":"L Grassi","year":"2014","unstructured":"Grassi L, Caruso R, Hammelef K, Nanni MG, Riba M. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry. 2014;26(1):44\u201362.","journal-title":"Int Rev Psychiatry"},{"key":"1739_CR16","volume":"5","author":"L Bai","year":"2020","unstructured":"Bai L, Xu Z, Huang C, Sui Y, Guan X, Shi L. Psychotropic medication utilisation in adult cancer patients in China: a cross-sectional study based on national health insurance database. Lancet Reg Health Am. 2020;5:100060.","journal-title":"Lancet Reg Health Am"},{"issue":"4","key":"1739_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/pon.3056","volume":"22","author":"CG Ng","year":"2013","unstructured":"Ng CG, Boks MP, Smeets HM, Zainal NZ, De Wit NJ. Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands. Psychooncology. 2013;22(4):762\u20137.","journal-title":"Psychooncology"},{"issue":"1","key":"1739_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"1739_CR19","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"issue":"9","key":"1739_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101710","volume":"31","author":"A Al-Azayzih","year":"2023","unstructured":"Al-Azayzih A, Jarab AS, Bani-Ahmad E, Smadi S, Kharaba Z, Al-Kubaisi KA. Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan. Saudi Pharm J. 2023;31(9):101710.","journal-title":"Saudi Pharm J"},{"key":"1739_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jgo.2020.12.007","volume":"126","author":"A Barlow","year":"2021","unstructured":"Barlow A, Prusak ES, Barlow B, Nightingale G. Interventions to reduce polypharmacy and optimize medication use in older adults with cancer. J Geriatr Oncol. 2021;126:863\u201371.","journal-title":"J Geriatr Oncol"},{"key":"1739_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/10499091211003078","volume":"391","author":"E Brokaar","year":"2022","unstructured":"Brokaar E, van den Bos F, MD P, Visser L, PharmaD P, Portielje J, et al. Deprescribing in older adults with cancer and limited life expectancy: an integrative review. Am J Hosp Palliat Care. 2022;391:86\u2013100.","journal-title":"Am J Hosp Palliat Care"},{"key":"1739_CR23","doi-asserted-by":"publisher","first-page":"9701","DOI":"10.3390\/curroncol30110704","volume":"3011","author":"G Chaput","year":"2023","unstructured":"Chaput G, Bhanabhai H, Deprescribing. A prime opportunity to optimize care of cancer patients. Curr Oncol Tor Ont. 2023;3011:9701\u20139.","journal-title":"Curr Oncol Tor Ont"},{"issue":"4","key":"1739_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100225","volume":"6","author":"GB Crawford","year":"2021","unstructured":"Crawford GB, Dzier\u017canowski T, Hauser K, Larkin P, Luque-Blanco AI, Murphy I, et al. Care of the adult cancer patient at the end of life: ESMO clinical practice guidelines. ESMO Open. 2021;6(4):100225.","journal-title":"ESMO Open"},{"issue":"3","key":"1739_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/pharmacy6030088","volume":"6","author":"F Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves F. Deprescription in advanced cancer patients. Pharmacy. 2018;6(3):88.","journal-title":"Pharmacy"},{"key":"1739_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104117","volume":"190","author":"C Herledan","year":"2023","unstructured":"Herledan C, Toulemonde A, Clairet AL, Boulin M, Falandry C, Decker LD, et al. Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: a position paper from SOFOG-SFPO. Crit Rev Oncol Hematol. 2023;190:104117.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"1739_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.6004\/jnccn.2022.7033","volume":"20","author":"TT Hshieh","year":"2022","unstructured":"Hshieh TT, DuMontier C, Jaung T, Bahl NE, Hawley CE, Mozessohn L, et al. Association of polypharmacy and potentially inappropriate medications with frailty among older adults with blood cancers. J Natl Compr Canc Netw. 2022;20(8):915-923.e5.","journal-title":"J Natl Compr Canc Netw"},{"key":"1739_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237431","author":"M Ko","year":"2023","unstructured":"Ko M, Kim S, Suh SY, Cho YS, Kim IW, Yoo SH, et al. Consultation-based deprescribing service to optimize palliative care for terminal cancer patients. J Clin Med. 2023;12(23). https:\/\/doi.org\/10.3390\/jcm12237431.","journal-title":"J Clin Med"},{"issue":"9","key":"1739_CR29","first-page":"4107","volume":"28","author":"H Marin","year":"2020","unstructured":"Marin H, Mayo P, Thai V, Dersch-Mills D, Ling S, Folkman F, et al. The impact of palliative care consults on deprescribing in palliative cancer patients. Support Care Cancer. 2020;28(9):4107\u201313.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1739_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11096-022-01506-4","volume":"45","author":"M Murphy","year":"2023","unstructured":"Murphy M, Bennett K, Wright M, O\u2019Reilly M, Conroy M, Hughes C, et al. Potentially inappropriate prescribing in older adults with cancer receiving specialist palliative care: a retrospective observational study. Int J Clin Pharm. 2023;45(1):174\u201383.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"1739_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jgo.2022.02.007","volume":"13","author":"J Novak","year":"2022","unstructured":"Novak J, Goldberg A, Dharmarajan K, Amini A, Maggiore RJ, Presley CJ, et al. Polypharmacy in older adults with cancer undergoing radiotherapy: a review. J Geriatr Oncol. 2022;13(6):778\u201383.","journal-title":"J Geriatr Oncol"},{"key":"1739_CR32","doi-asserted-by":"crossref","unstructured":"Ramsdale E, Malhotra A, Holmes HM, Zubkoff L, Wang J, Mohile S et al. Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2023;31(12):636.","DOI":"10.1007\/s00520-023-08084-9"},{"issue":"2","key":"1739_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2023.101687","volume":"15","author":"E Ramsdale","year":"2024","unstructured":"Ramsdale E, Mohamed M, Holmes HM, Zubkoff L, Bauer J, Norton SA, et al. Decreasing polypharmacy in older adults with cancer: a pilot cluster-randomized trial protocol. J Geriatr Oncol. 2024;15(2):101687.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"1739_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/15360288.2023.2288093","volume":"38","author":"A Riveras","year":"2024","unstructured":"Riveras A, Crul M, van der Kloes J, Steegers M, Huisman B. A tool for deprescribing antithrombotic medication in palliative cancer patients: a retrospective evaluation. J Pain Palliat Care Pharmacother. 2024;38(1):20\u20137.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"1739_CR35","doi-asserted-by":"crossref","unstructured":"Sakran R, Litvak M, Haim N, Kurnik D. Deprescribing in hospitalized patients with cancer: A clinical pharmacist-initiated multidisciplinary intervention. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract. 2024;10781552241294016.","DOI":"10.1177\/10781552241294016"},{"issue":"4","key":"1739_CR36","first-page":"2933","volume":"30","author":"LN van Merendonk","year":"2022","unstructured":"van Merendonk LN, Crul M. Deprescribing in palliative patients with cancer: a concise review of tools and guidelines. Support Care Cancer. 2022;30(4):2933\u201343.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1739_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/ejhpharm-2021-003143","volume":"31","author":"LN Van Merendonk","year":"2024","unstructured":"Van Merendonk LN, Peters BJM, M\u00f6hlmann JE, Hunting CB, Kastelijn EA, Van Den Broek MPH. The potential for deprescribing in a palliative oncology patient population: a cross-sectional study. Eur J Hosp Pharm. 2024;31(1):10\u20135.","journal-title":"Eur J Hosp Pharm"},{"key":"1739_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s41999-021-00475-7","volume":"123","author":"EP Van Poelgeest","year":"2021","unstructured":"Van Poelgeest EP, Pronk AC, Van Der Rhebergen D. Depression, antidepressants and fall risk: therapeutic dilemmas\u2014a clinical review. Eur Geriatr Med. 2021;123:585\u201396.","journal-title":"Eur Geriatr Med"},{"key":"1739_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SPC.0000000000000634","volume":"171","author":"A Whitman","year":"2023","unstructured":"Whitman A, Fitch E, Nightingale G. The role of oncology pharmacists and comprehensive medication reconciliation in informing treatment plans for older adults with cancer and downstream outcomes. Curr Opin Support Palliat Care. 2023;171:3\u20137.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1739_CR40","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;i4919.","DOI":"10.1136\/bmj.i4919"},{"key":"1739_CR41","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00228-018-2507-4","volume":"7410","author":"L Morin","year":"2018","unstructured":"Morin L, Laroche ML, Vetrano DL, Fastbom J, Johnell K. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol. 2018;7410:1333\u201342.","journal-title":"Eur J Clin Pharmacol"},{"key":"1739_CR42","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1177\/10781552231207839","volume":"298","author":"B Raju","year":"2023","unstructured":"Raju B, Chaudhary R, Babu LA, Sandeep A, Mateti A. Rationalizing prescription via deprescribing in oncology practice. J Oncol Pharm Pr. 2023;298:2007\u201313.","journal-title":"J Oncol Pharm Pr"},{"issue":"4","key":"1739_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13061","volume":"72","author":"D Garfinkel","year":"2018","unstructured":"Garfinkel D, Ilin N, Waller A, Torkan-Zilberstein A, Zilberstein N, Gueta I. Inappropriate medication use and polypharmacy in end-stage cancer patients: isn\u2019t it the family doctor\u2019s role to de-prescribe much earlier? Int J Clin Pract. 2018;72(4):e13061.","journal-title":"Int J Clin Pract"},{"key":"1739_CR44","first-page":"1287","volume":"215","author":"TT Yeoh","year":"2013","unstructured":"Yeoh TT, Si P, Chew L. The impact of medication therapy management in older oncology patients. Support Care Cancer. 2013;215:1287\u201393.","journal-title":"Support Care Cancer"},{"key":"1739_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"442","author":"D O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;442:213\u20138.","journal-title":"Age Ageing"},{"issue":"2","key":"1739_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2710.2007.00815.x","volume":"32","author":"KC Sokol","year":"2007","unstructured":"Sokol KC, Knudsen JF, Li MM. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther. 2007;32(2):169\u201375.","journal-title":"J Clin Pharm Ther"},{"key":"1739_CR47","first-page":"71","volume":"231","author":"J Lindsay","year":"2015","unstructured":"Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, et al. The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2015;231:71\u20138.","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"1739_CR48","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/acr2.11503","volume":"412","author":"J Lee","year":"2022","unstructured":"Lee J, Singh N, Gray S, Makris U. Optimizing medication use in older adults with rheumatic musculoskeletal diseases: deprescribing as an approach when less may be more. ACR Open Rheumatol. 2022;412:1031\u201341.","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"1739_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amjopharm.2009.05.002","volume":"7","author":"KL Flood","year":"2009","unstructured":"Flood KL, Carroll MB, Le CV, Brown CJ. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an Oncology-Acute care for elders unit. Am J Geriatr Pharmacother. 2009;7(3):151\u20138.","journal-title":"Am J Geriatr Pharmacother"},{"key":"1739_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.13185","author":"E Vrijkorte","year":"2020","unstructured":"Vrijkorte E, de Vries J, Schaafsma R, Wymenga M, Oude Munnink T. Optimising pharmacotherapy in older cancer patients with polypharmacy. Eur J Cancer Care. 2020;29. https:\/\/doi.org\/10.1111\/ecc.13185.","journal-title":"Eur J Cancer Care"},{"issue":"S1","key":"1739_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13012-017-0688-3","volume":"13","author":"S Lewin","year":"2018","unstructured":"Lewin S, Booth A, Glenton C, Munthe-Kaas H, Rashidian A, Wainwright M, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series. Implement Sci. 2018;13(S1):2\u2013s13012.","journal-title":"Implement Sci"},{"key":"1739_CR52","doi-asserted-by":"crossref","unstructured":"Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL et al. Safety and benefit of discontinuing Statin therapy in the setting of Advanced, Life-Limiting illness: A randomized clinical trial. JAMA Intern Med. 2015;175(5):691.","DOI":"10.1001\/jamainternmed.2015.0289"},{"key":"1739_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1116583","volume":"11","author":"X Wang","year":"2023","unstructured":"Wang X, Yang C, Jiang J, Hu Y, Hao Y, Dong JY. Polypharmacy, chronic kidney disease, and mortality among older adults: a prospective study of National Health and nutrition examination survey, 1999\u20132018. Front Public Health. 2023;11:1116583.","journal-title":"Front Public Health"},{"issue":"658","key":"1739_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3399\/bjgp17X690857","volume":"67","author":"D Kernick","year":"2017","unstructured":"Kernick D, Chew-Graham CA, O\u2019Flynn N. Clinical assessment and management of multimorbidity: NICE guideline. Br J Gen Pract. 2017;67(658):235\u20136.","journal-title":"Br J Gen Pract"},{"key":"1739_CR55","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"674","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American geriatrics society 2019 updated AGS beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;674:674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1739_CR56","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jgo.2016.07.010","volume":"7","author":"M Sharma","year":"2016","unstructured":"Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM. Polypharmacy and potentially inappropriate medication use in geriatric oncology. J Geriatr Oncol. 2016;7(5):346\u201353.","journal-title":"J Geriatr Oncol"},{"key":"1739_CR57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/15360288.2016.1204411","volume":"303","author":"L Oliveira","year":"2016","unstructured":"Oliveira L, Ferreira MO, Rola A, Magalh\u00e3es M, Ferraz Gon\u00e7alves J. Deprescription in advanced cancer patients referred to palliative care. J Pain Palliat Care Pharmacother. 2016;303:201\u20135.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"12","key":"1739_CR58","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1111\/bcp.13735","volume":"84","author":"A Todd","year":"2018","unstructured":"Todd A, Al-Khafaji J, Akhter N, Kasim A, Quibell R, Merriman K, et al. Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life \u2013 an international cohort study. Br J Clin Pharmacol. 2018;84(12):2802\u201310.","journal-title":"Br J Clin Pharmacol"},{"key":"1739_CR59","first-page":"568","volume-title":"The maudsley: deprescribing guidelines: antidepressants, benzodiazepines, gabapentinoids and Z-drugs","author":"M Horowitz","year":"2024","unstructured":"Horowitz M, Taylor DM. The maudsley: deprescribing guidelines: antidepressants, benzodiazepines, gabapentinoids and Z-drugs. Hoboken, USA West Sussex, UK: Wiley Blackwell; 2024. p. 568."},{"key":"1739_CR60","unstructured":"McCarthy L, Thompson W, Farrell B. Deprescribing.org. [cited 2024 Dec 18]. Deprescribing Guidelines and Algorithms. Available from: https:\/\/deprescribing.org\/resources\/deprescribing-guidelines-algorithms\/"},{"key":"1739_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/j.2055-2335.2011.tb00684.x","volume":"412","author":"JE Hardy","year":"2011","unstructured":"Hardy JE, Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res. 2011;412:146\u201351.","journal-title":"J Pharm Pract Res"},{"key":"1739_CR62","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1136\/bmj.302.6785.1136","volume":"3026785","author":"FG Fowkes","year":"1991","unstructured":"Fowkes FG, Fulton PM. Critical appraisal of published research: introductory guidelines. BMJ. 1991;3026785:1136\u201340.","journal-title":"BMJ"},{"key":"1739_CR63","doi-asserted-by":"crossref","unstructured":"McGuinness LA, Higgins JPT. Risk-of\u2010bias VISualization (robvis): an R package and Shiny web app for visualizing risk\u2010of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361.","DOI":"10.1002\/jrsm.1411"},{"key":"1739_CR64","doi-asserted-by":"crossref","unstructured":"Fede A, Miranda M, Antonangelo D, Trevizan L, Schaffhausser H, Hamermesz B, et al. Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer. 2011;19(9):1313\u20138.","DOI":"10.1007\/s00520-010-0947-1"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01739-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01739-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01739-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:02:02Z","timestamp":1775545322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-026-01739-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01739-w","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"38"}}